About RenovoRx, Inc. 
RenovoRx, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 4 Schemes (5.86%)
Foreign Institutions
Held by 2 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
USD 42 Million ()
NA (Loss Making)
NA
0.00%
-1.15
-101.49%
3.93






